Open original FDA record ↗Recall record
- FDA identifier
- Z-0945-2022
- Company in FDA record
- Acon Biotech (Hangzhou) Co., Ltd.
- FDA record creation date
- Apr 15, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Non-EUA authorized, CE marked, SARS-CoV-2 antigen rapid test kits are being recalled from the U.S. market because use may lead to inaccurate test results, including false negative or false positive test results.
Source facts
- Action
- On 04/04/22, recall notices were sent to distributor customers who were asked to do the following: If you may have further distributed this product, please identify your customers and notify them at once of this product correction. Your notification to your customers may be enhanced by including a copy of this correction notification letter. This correction should be carried out to the consumer/user level in U.S. Complete and return the response form to the recalling firm. Customers with additional questions were encouraged to contact Denice Dong, Denice.Dong@aconlab.com.cn Additional instructions in a press release were provided to address affected non-EUA devices, of unknown quantity, that may have entered the U.S. market. It is recommended to stop use and dispose of affected devices in the U.S. market: https://www.aconlabs.com/news/
- Initiated
- 2022-01-09
- Root cause
- No Marketing Application
- Distribution
- US: MD, PA International Distribution to countries of: Hungary and China.
- Recall number
- Z-0945-2022
- Recall status
- Open, Classified
- CDRH record ID
- 192365
- FDA record created
- 2022-04-15
- Recall event number
- 89755